New cervical artificial disc earns expanded coverage: 3 things to know

Mackenzie Garrity -   Print  |

Globus Medical's Secure-C Cervical Artificial Disc was granted expanded coverage by Anthem.

Three things to know:

1. The FDA approved the cervical artificial disc in 2012. Globus Medical designed the disc for reconstruction and motion perseveration at the operated disc level.

2. Globus Medical published a long term, seven-year clinical trial in the International Journal of Spine Surgery outlining the success of the Secure-C compared to traditional anterior cervical discectomy and fusion.

3. At seven-year post-operative follow-up, patients treated with Secure-C exhibited the following results compared to patients treated with ACDF:

• Statistically superior composite protocol-specified overall success results (86.3 percent vs. 70 percent)
• Statistically superior composite FDA-defined overall success results (79.2 percent vs. 63.6 percent)
• Greater percentage of patients with at least 25 percent improvement in Neck Disability Index (90.4 percent vs. 86 percent)
• Lower rate of subsequent surgery at the original treated level (4.2 percent vs. 15.3 percent)
• Lower rate of adjacent level surgery (4.2 percent vs. 16 percent)

More articles on devices and implants:
Nextech acquires EMR solution for orthopedic practices: 3 details
How China-US tariff tension affects orthopedic companies; Moody's thinks they'll adapt
3 things to know about AxioMed

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers